TITLE

Exacerbation of thyroid associated ophthalmopathy after arterial embolization therapy in a patient with Graves’ disease

AUTHOR(S)
Tetsuya Hiraiwa; Akihisa Imagawa; Kazuhiro Yamamoto; Hiroshi Arimoto; Takeshi Arishima; Mitsuru Ito; Yasushi Nakamura; Fumio Matsuzuka; Akira Miyauchi; Jun Sugasawa; Tsunehiko Ikeda; Yoshifumi Narumi; Toshiaki Hanafusa
PUB. DATE
June 2009
SOURCE
Endocrine (1355008X);Jun2009, Vol. 35 Issue 3, p302
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract  A novel treatment approach to Graves’ disease (GD), embolization of the thyroid gland arteries, is evaluated with respect to its indications and adverse effects. We describe an exacerbation of thyroid associated ophthalmopathy (TAO) following thyroid artery embolization in a woman with GD and mild stable TAO (NOSPECS classification, class I grade a). A 45-year-old woman with GD and inactive TAO, in whom thyroid function was stable following blockade of hormone release combined with replacement therapy, underwent embolization of three thyroid arteries. Initially, there were neither adverse effects nor complications; however, the patient developed severe TAO (NOSPECS classification, class IV grade b) 3 months after the arterial embolization. Steroid pulse treatments followed by total thyroidectomy resulted in improvement of the eye signs and symptoms. The clinical course and the serial changes of the thyroglobulin and thyroglobulin-antibody titers suggested that the destruction of thyroid follicles, induced by the arterial embolization, triggered the exacerbation of her TAO. Our experience argues for the use of caution when arterial embolization is considered for GD patients with even the mildest TAO (NOSPECS classification, class I).
ACCESSION #
40419558

 

Related Articles

  • Effect of Near-Total Thyroidectomy on Thyroid Orbitopathy Due to Toxic Goiter. Elsayed, Yasser A.; Abdul-Latif, Atif M.; Abu-Alhuda, Mukhtar F.; Halim, Hosam A-F. // World Journal of Surgery;Apr2009, Vol. 33 Issue 4, p758 

    The relative merit of surgery in the treatment of Graves’ ophthalmopathy as well as the extent of surgical resection are still matters of debate. This study aimed at reporting an assessment of the impact of near-total thyroidectomy on the course of ophthalmopathy including exophthalmos. A...

  • Oftalmopatía tiroidea: reporte de caso y revisión de la literatura. Cuéllar, René Bourlon; Martínez Balbuena, María Micaela; Mora Arias, Tania Teresa; Urquiza, Rafael Vera; Hernández, Salvador Pimentel // Medicina Interna de Mexico;nov/dic2010, Vol. 26 Issue 6, p616 

    No abstract available.

  • Critical issues on Graves' ophthalmopathy. Rocchi, Roberto // MLO: Medical Laboratory Observer;May2006, Vol. 38 Issue 5, p10 

    The article offers information on graves' ophthalmopathy (GO). It is an inflammatory process that affects tissues of the orbit in patients with Graves' disease (GD) and, some times, with Hashimoto's thyroiditis. GO is a disfiguring disease that impairs the quality of life of affected patients....

  • Genetic susceptibility to Graves’ ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes. Anvari, M.; Khalilzadeh, O.; Esteghamati, A.; Esfahani, S. A.; Rashidi, A.; Etemadi, A.; Mahmoudi, M.; Amirzargar, A. A. // Eye;Jun2010, Vol. 24 Issue 6, p1058 

    PurposeIn order to investigate the underlying genetic mechanisms of Graves’ ophthalmopathy (GO), we examined the association between single-nucleotide polymorphisms in five important proinflammatory cytokines, namely IL-12, TNF-α, IFN-γ, IL-2, and IL-6, with GO in a sample of...

  • Management of Grave's Disease Is Improved by Total Thyroidectomy. Annerbo, Maria; Stålberg, Peter; Hellman, Per // World Journal of Surgery;Aug2012, Vol. 36 Issue 8, p1943 

    Background: A retrospective analysis was performed on 267 consecutive patients with Graves' disease (GD). The principal aim of this study was to evaluate the risk for recurrence and complications when changing the surgical method from subtotal (ST) to total thyroidectomy (TT). Methods:...

  • Safety, Efficacy, and Cost Savings of Single Parathyroid Hormone Measurement for Risk Stratification after Total Thyroidectomy. McCULLOUGH, MEGHAN; WEBER, COLLIN; LEONG, CHRIS; SHARMA, JYOTIRMAY // American Surgeon;Aug2013, Vol. 79 Issue 8, p768 

    The management of hypocalcemia (HC) after total thyroidectomy (TTx) is a challenge as TTx is transitioned into a same-day surgery. Measurement of parathyroid hormone (PTH) level after TTx may allow for prediction of postoperative HC and lead to shorter hospital stays. A prospective database was...

  • Delayed Graves' Ophthalmopathy. Nebesio, Todd D.; Eugster, Erica A. // New England Journal of Medicine;5/6/2010, Vol. 362 Issue 18, pe60 

    The article describes the clinical care of an 18-year-old man who developed delayed Graves' ophthalmopathy.

  • Doesn't Graves' disease cause bulging eyes? My brother was diagnosed with Graves' disease several years ago, but his eyes appear to be unchanged.  // Mayo Clinic Health Letter;Feb2012, Vol. 30 Issue 2, p8 

    The article provides an answer to a question about Graves' disease.

  • Clinical Spectrum of Graves' Orbitopathy. Heggie, Alison; Perros, Petros // Immunology, Endocrine & Metabolic Agents - Medicinal Chemistry;Jun2011, Vol. 11 Issue 2, p83 

    GO is common in patients with Graves' disease and is associated with significant morbidity. The clinical presentation is varied and often the diagnosis is delayed. Careful clinical assessment usually leads to an accurate diagnosis, though in a minority of atypical presentations imaging and other...

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics